All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-37059256

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	37059256	A222V	S	S	COVID-19	R S L	View
2	37059256	A831V	S	S	COVID-19	R S L	View
3	37059256	D614G	S	S	COVID-19	R S L	View
4	37059256	D80Y	S	S	COVID-19	R S L	View
5	37059256	E484K	S	S	COVID-19	R S L	View
6	37059256	F490S	S	S	COVID-19	R S L	View
7	37059256	L452R	S	S	COVID-19	R S L	View
8	37059256	N440K	S	S	COVID-19	R S L	View
9	37059256	N501Y	S	S	COVID-19	R S L	View
10	37059256	P681H	S	S	COVID-19	R S L	View
11	37059256	P681R	S	S	COVID-19	R S L	View
12	37059256	R346K	S	S	COVID-19	R S L	View
13	37059256	R346S	S	S	COVID-19	R S L	View
14	37059256	S98F	S	S	COVID-19	R S L	View
15	37059256	R436K	RBD	S	COVID-19	R S L	View
16	37059256	R436S	RBD	S	COVID-19	R S L	View
17	37059256	Q27X	ORF8	ORF8	COVID-19	R S L	View
18	37059256	P314L	ORF1b	ORF1b	COVID-19	R S L	View
19	37059256	T1001I	ORF1ab	ORF1ab	COVID-19	R S L	View
20	37059256	S235F	N	N	COVID-19	R S L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.